The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) Federal officials today unveiled recommendations for nonpharmaceutical steps to battle pandemic influenza, tying them to a new "Pandemic Severity Index" (PSI), similar to the system for categorizing hurricanes.
(CIDRAP News) Dr. Anne Francis, a pediatrician in Rochester, N.Y., says her group practice typically has a few doses of influenza vaccine left at the end of the flu season. But as of last week, with the demand for vaccination nearly gone, the clinic still had 580 doses on hand.
(CIDRAP News) The H5N1 avian influenza situation in Asia remained active today as Indonesia began clearing Jakarta of backyard fowl to curb the spread of the disease, Vietnam fought a poultry outbreak in an eighth province, and Thailand tested several people for suspected infections.
(CIDRAP News) A virus recovered from victims of the 1918 influenza pandemic kills by replicating so rapidly that it revs the immune system into overdrive, turning the body against itself, a team of scientists report in today's issue of the journal Nature.
(CIDRAP News) – In an effort to stretch the nation's supply of vaccines for a potential influenza pandemic, federal health officials today announced contracts totaling $132.5 million to help three companies develop dose-sparing substances, or adjuvants, to be used with H5N1 flu vaccines.
(CIDRAP News) – In an effort to expand the pool of antiviral drugs for influenza, the US government yesterday awarded a $102.6 million contract to BioCryst Pharmaceuticals Inc. of Birmingham, Ala., to develop peramivir, a new neuraminidase inhibitor.
(CIDRAP News) – California scientists report that their analysis of the medical literature has yielded data on more than 600 molecular components of influenza A viruses that trigger immune responses, findings they hope will spur the search for vaccines offering protection against multiple flu strains.
(CIDRAP News) Scientists who analyzed mortality records from the 1918 influenza pandemic estimate that a similarly severe pandemic today would kill about 62 million people worldwide, the vast majority of them in the developing world.
(CIDRAP News) Two studies reported in today's issue of the New England Journal of Medicine provide additional support for seasonal influenza immunization while shedding some light on questions about vaccination strategies and the efficacy of the vaccines.
(CIDRAP New) – The Institute of Medicine (IOM) weighed in with a clear "maybe" this week on whether community interventions such as school closures, quarantine, and respiratory etiquette could help blunt the impact of an influenza pandemic.
